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S U M M A R Y
Background: Pediatric Pseudomonas aeruginosa bacteremia is uncommon. It is mostly seen with impaired
immune defenses and is most often nosocomially acquired, but it does occasionally occur in the
previously healthy. Empiric antibiotics not effective against P. aeruginosa can result in poor outcomes. To
determine the risk factors for P. aeruginosa bacteremia, all pediatric cases of P. aeruginosa bacteremia
hospitalized at a single center over a 5-year period were reviewed.
Methods: A retrospective cohort study (2006–2010) of P. aeruginosa bacteremia in children under 14
years of age assessing demographics, the presence of underlying diseases, whether nosocomially
acquired, clinical and laboratory ﬁndings, P. aeruginosa antibiotic susceptibility, antibiotic therapy, and
clinical outcomes was performed.
Results: Thirty-one children, mean age 46 months, had P. aeruginosa bacteremia (2.6% positive blood
cultures); 18 cases were nosocomial, none were multi-resistant, and 13 (42%) had P. aeruginosa isolated
from a site other than blood. Ten cases occurred in previously healthy children, all of which were
community-acquired, and these children were more likely to present with seizures and gastrointestinal
ﬁndings than those with underlying conditions. The overall case fatality rate was 52% (16/31); 6/16 were
previously healthy. Fatal cases had more leukopenia, elevated aspartate aminotransferase, and lower
prealbumin A. Fewer fatal cases (6/16 vs. 14/15) had initial antibiotic coverage effective for P. aeruginosa
(p = 0.002). No difference in case fatality rate (p > 0.05) or antibiotic sensitivity (p > 0.05) was found
between community-acquired and nosocomial cases.
Conclusions: P. aeruginosa bacteremia in children is rare but often fatal if initial antibiotics do not cover P.
aeruginosa. Factors indicative of P. aeruginosa bacteremia remain elusive, especially in previously healthy
young children. However, P. aeruginosa bacteremia should be considered if children present with a grave
illness, seizures, serious gastrointestinal ﬁndings, hypotension, and leukopenia.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Pseudomonas aeruginosa sepsis in childhood is uncommon and
most often occurs in patients with underlying diseases that
impair defense mechanisms, such as those with malignancies,
burns, immunodeﬁciencies, and prematurity.1–6 Many of these
infections are nosocomial.1,2 P. aeruginosa is also an uncommon
cause of bacteremia in previously healthy infants and children
with community-acquired fever and presumed sepsis; so
uncommon that initial antibiotic recommendations for such
patients do not routinely include agents effective against this
microbe.3 Community-acquired P. aeruginosa sepsis has been* Corresponding author. Tel.: +1 902 470 8498.
E-mail address: noni.macdonald@dal.ca (N.E. MacDonald).
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http://dx.doi.org/10.1016/j.ijid.2012.03.014reported in previously healthy children, albeit infrequently.2,4–12
Given that the outcome of P. aeruginosa bacteremia may be poor
unless early antibiotic coverage is active against the organism,
protocols for the management of children with malignancy and
febrile neutropenia recommend broad-spectrum initial antimi-
crobials that include coverage for P. aeruginosa, even though most
of these children will not have bacteremia due to this microbe. In
order to optimize the initial management of children with serious
P. aeruginosa sepsis one needs to know when P. aeruginosa
bacteremia should be suspected, both in children with known
risk factors such as febrile neutropenia and malignancy, as well as
in children without recognized risk factors. Therefore, we
retrospectively reviewed all cases of infants and children
hospitalized with P. aeruginosa bacteremia during a 5-year
period at The Children’s Hospital afﬁliated with Soochow
University in southern China.ses. Published by Elsevier Ltd. All rights reserved.
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The Children’s Hospital afﬁliated with Soochow University
serves as the pediatric tertiary care referral center for admissions
for those less than 14 years of age in the Greater Suzhou Area and
the surrounding South China region. In 2006, there were 8.26
million people in Suzhou itself, with a pediatric population (0
to < 14 years) of 1.2 million. By 2010, the population in Suzhou had
risen to 13 million, with a pediatric population of 1.5 million. The
average number of admissions per year to this hospital is about
25 000.
The case deﬁnition for inclusion in this cohort study was
admission to the Children’s Hospital afﬁliated with Soochow
University between January 1, 2006, and December 31, 2010,
having a blood culture positive for P. aeruginosa, with clinical and
laboratory evidence of infection. A bloodstream infection was
considered to be present if two separate blood cultures grew only
P. aeruginosa identiﬁed using standard techniques. Bloodstream
infections were considered primary if the source was unknown or
was related to intravenous therapy, or secondary if there was a
focal infection. Community-acquired infection was deﬁned as
positive blood cultures drawn on admission provided the patient
had not been hospitalized in the previous 2 weeks. Infections were
regarded as nosocomial if they occurred 72 h or more after
admission to hospital.8 Only stool cultures with a pure growth of P.
aeruginosa were considered to be positive for the microbe.
Children were considered previously healthy if they had no
history of prior hospitalization, had no identiﬁed underlying
condition known to increase the risk of P. aeruginosa bacteremia
such as malignancy, burns, immunodeﬁciency, or prematurity, and
had no predisposing factors such as indwelling vascular catheters,
steroid therapy, or required mechanical ventilation.
For all children eligible for inclusion in the study, the medical
records were reviewed using a standardized form for the collection
of demographic data, presence of underlying diseases, clinical
manifestations, laboratory data, antibiotic susceptibility of P.
aeruginosa, initial and subsequent antibiotic therapy, and clinical
outcome, as well as determination of whether the infection was
community-acquired or nosocomial according to the above
criteria. Initial treatment was deemed appropriate if the antibiotic
regimen administered within 24 h of blood having been drawn forTable 1
Demographics, underlying conditions, and outcomes of the 31 children with Pseudomo
Total
(N = 31)
Age
Mean age in months 46 
Age range in months 1–168 
<1 year 13/31 (42%)
>1 year to <2 years 2/31 (7%) 
>2 years to <5 years 8/31 (26%) 
>5 years 8/31 (26%) 
Gender
Male 15/31 (48%)
Underlying conditions
Present 21/31 (68%)
Acute lymphoblastic leukemia 11/31 (35%)
Acute myeloblastic leukemia 4/31 (13%) 
Aplastic anemia 1/31 (3%) 
Hemophagocytic syndrome 1/31 (3%) 
Severe combined immunodeﬁciency 1/31 (3%) 
Premature and very low birth weight 2/31 (7%) 
Congenital heart disease and malnutrition 1/31 (3%) 
Absent 10 (32%) 
Pseudomonas aeruginosa bacteremia
Community-acquired 13/31 (42%)
Nosocomial 18/31 (58%)culture included at least one drug active in vitro against the
subsequently isolated P. aeruginosa microbe and known to be
effective in clinical trials.
Fisher’s exact test was performed for dichotomous categorical
variables. Continuous data were tested by means of the Wilcoxon
rank sum test. A p-value of <0.05 was considered statistically
signiﬁcant. The data analysis was conducted using SPSS statistical
software.
The study was approved by the Research Ethics Board of the
Children’s Hospital afﬁliated with Soochow University. The study
was funded by Soochow University.
3. Results
Over the 5-year period, the number of children with a positive P.
aeruginosa blood culture varied from two to nine per year, with a
total of 31 infants and children meeting the criteria for inclusion in
the study. These children represented 2.64% of the children with
positive blood cultures over the time-period (average number of
blood cultures collected per year 690; average annual number
positive 235).
The demographics, underlying conditions, whether the P.
aeruginosa bacteremia was community-acquired or nosocomial,
and outcomes of the 31 patients are shown in Table 1. None had
more than one admission with P. aeruginosa bacteremia during the
study period. Previously healthy children were younger (mean age
9 months; range 1–24 months) than those patients with
underlying conditions (mean age 75 months; range 1–168 months;
p < 0.001) and were more likely to have community-acquired P.
aeruginosa bacteremia (10/10 vs. 3/21, p < 0.001).
Sixteen children died, six of whom were previously healthy,
giving an overall case fatality rate of 52% (Table 1). A comparison of
the fatality rate between previously healthy children and children
with underlying conditions was not statistically signiﬁcant (6/10
vs. 10/21, respectively; p > 0.05). Similarly, there was no signiﬁ-
cant difference in fatality rates between community-acquired and
nosocomial cases (9/13 vs. 7/18, respectively; p > 0.05). All seven
of the fatal nosocomial cases occurred in children with an
underlying condition.
Table 2 provides information on the presenting symptoms and
signs in the 31 children with P. aeruginosa bacteremia, and presentsnas aeruginosa bacteremia
Non-fatal cases
(n = 15)
Fatal cases
(n = 16)
61 31
6–168 1–168
 3/15 (20%) 10/16 (63%)
1/15 (7%) 1/16 (6%)
5/15 (33%) 3/16 (19%)
6/15 (40%) 2/16 (13%)
 6/15 (40%) 9/16 (56%)
 11/15 (73%) 10/16 (63%)
 8/15 (53%) 3/16 (19%)
3/15 (20%) 1/16 (6%)
0/15 (0%) 1/16 (6%)
0/15 (0%) 1/16 (6%)
0/15 (%) 1/16 (6%)
0/15 (0%) 2/16 (13%)
0/15 (0%) 1/16 (6%)
4/15 (27%) 6/16 (38%)
 7/15 (47%) 9/16 (56%)
 8/15 (53%) 7/16 (44%)
Table 2
Comparison of age, gender, clinical ﬁndings, and outcomes in children with Pseudomonas aeruginosa bacteremia between previously healthy children and those with
underlying conditions and between fatal and non-fatal cases
Total
(N = 31)
Previously healthy
(n = 10)
Underlying condition
(n = 21)
p-Value Non-fatal
(n = 15)
Fatal
(n = 16)
p-Value
Age
Mean in months 45.68 9.1 75 <0.001 61 31 NS
Range in months 1–168 1–24 1–168 6–168 1–168
Gender
Male 15/31 (48%) 7/10 (70%) 8/21 (38%) NS 6/15 (40%) 9/16 (56%) NS
Symptoms and signs
Decreased activity 31/31 (100%) 10/10 (100%) 21/21 (100%) NS 15/15 (100%) 16/16 (100%) NS
Fever (rectal temp. >38 8C) 28/31 (90%) 8/10 (80%) 20/21 (95%) NS 13/15 (87%) 15/16 (94%) NS
Poor feeding 31/31 (100%) 10/10 (100%) 21/21 (100%) NS 15/15 (100%) 16/16 (100%) NS
Vomiting 5/31 (16%) 5/10 (50%) 0/21 (0%) 0.001 1/15 (7%) 4/16 (25%) NS
Diarrhea 18/31 (58%) 5/10 (50%) 13/21 (62%) NS 10/15 (67%) 8/16 (50%) NS
Abdominal distension 10/31 (32%) 6/10 (60%) 4/21 (19%) 0.025 1/15 (7%) 9/16 (56%) 0.006
Cough 10/31 (32%) 1/10 (10%) 9/21 (43%) NS 5/15 (33%) 5/16 (31%) NS
Dyspnea 9/31 (29%) 4/10 (40%) 5/21 (24%) NS 2/15 (13%) 7/16 (44%) NS
Skin lesions 7/31 (23%) 4/10 (40%) 3/21 (14%) NS 1/15 (7%) 6/16 (38%) NS
Seizure 8/31 (26%) 7/10 (70%) 1/21 (5%) <0.001 2/15 (13%) 6/16 (38%) NS
Tachycardia 31/31 (100%) 10/10 (100%) 21/21 (100%) NS 15/15 (100%) 16/16 (100%) NS
Hypotension/shock 9/31 (29%) 5/10 (50%) 4/21 (19%) NS 0/15 (0%) 9/16 (56%) 0.001
GI hemorrhage 9/31 (29%) 6/10 (60%) 3/21 (14%) 0.010 0/15 (0%) 9/16 (56%) 0.001
Jaundice 7/31 (23%) 2/10 (20%) 5/21 (24%) NS 1/15 (7%) 6/16 (38%) NS
Outcomes
Multi-organ system dysfunction 17/31 (55%) 5/10 (50%) 12/21 (57%) NS 5/15 (33%) 12/16 (75%) 0.018
Death 16/31 (52%) 6/10 (60%) 10/21 (48%) NS 0/15 16/16
GI, gastrointestinal; NS, not signiﬁcant.
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underlying conditions and of non-fatal cases to fatal cases.
Children with P. aeruginosa bacteremia commonly presented with
decreased activity (100%), fever (rectal temperature >38 8C) (90%),
poor feeding (100%), diarrhea (58%), and tachycardia (100%). The
duration of fever before admission ranged from 2 to 15 days, with a
mean of 5.16 days (median 5 days). Signiﬁcantly more of the
previously healthy children presented with seizures (7/10 vs. 1/21;
p < 0.001), vomiting (5/10 vs. 0/21; p = 0.001), abdominal disten-
sion (6/10 vs. 4/21; p < 0.05), and gastrointestinal (GI) hemorrhageTable 3
Comparison of laboratory ﬁndings expressed as percent abnormal value in children with
with underlying conditions and between fatal and non-fatal cases
Total
(N = 31)
Previously healthy
(n = 10)
Und
cond
(n = 
Test (% abnormal)
WBC (<2  109/l) 21/31 (68%) 6/10 (60%) 15/2
Neutropenia (ANC <0.5  109/l) 21/31 (68%) 6/10 (60%) 15/2
Platelets (<50  109/l) 19/31 (61%) 3/10 (30%) 16/2
Anemia (Hb <110 g/l) 26/31 (84%) 7/10 (70%) 19/2
CRP (>8 mg/l) 22/30 (73%) 7/9 (78%) 15/2
Glucose (>6.4 or <2.2 mmol/l) 13/20 (65%) 5/9 (56%) 8/11
Hyponatremia (<130 mmol/l) 25/31 (81%) 7/10 (70%) 18/2
Creatinine (>104 U/l) 6/26 (23%) 2/10 (20%) 4/16
Creatinine kinase (>225 U/l) 6/22 (27%) 2/8 (25%) 4/14
AST (>67 U/l) 9/26 (35%) 4/10 (40%) 5/16
ALT (>35 U/l) 12/26 (46%) 3/10 (30%) 9/16
Prealbumin A (<170 mg/l) 21/26 (81%) 10/10 (100%) 11/1
Albumin (<39 g/l) 20/22 (91%) 10/10 (100%) 10/1
Total bilirubin (>17 mmol/l) 7/21 (33%) 3/10 (30%) 4/11
LDH (>382 U/l) 16/26 (62%) 6/10 (60%) 10/1
Microbiology
P. aeruginosa in blood 31/31 (100%) 10 (100%) 21/2
P. aeruginosa also isolated from
another site
13/31 (42%) CSF 2/10 (20%);
sputum 1/10 (10%);
peritoneal 2/10 (20%);
pleural 2/10 (20%);
skin lesions 3/10 (30%)
Stoo
(33%
Initial antibiotic coverage for
P. aeruginosa
20/31 (65%) 5/10 (50%) 15/2
ALT, aspartate aminotransferase; ANC, absolute neutrophil count; AST, aspartate aminot
lactate dehydrogenase; NS, not signiﬁcant; WBC, white blood cell count.(6/10 vs. 3/21; p = 0.01) than did those with underlying conditions.
Children with a fatal illness were more likely to present with
hypotension and shock (9/16 vs. 0/15; p = 0.001), abdominal
distension (9/16 vs. 1/15; p < 0.01), and GI hemorrhage (9/16 vs. 0/
15; p = 0.001). Skin lesions occurred in seven children, four with
ecthyma gangrenosum (all fatal; all previously healthy) and three
with petechiae or purpura (all non-fatal).
In 13 of the 31 (42%) children with P. aeruginosa bacteremia, the
microbe was also isolated from sites beyond the bloodstream
(Table 3). Respiratory and stool viral testing for common Pseudomonas aeruginosa bacteremia between previously healthy children and those
erlying
ition
21)
p-Value Non-fatal
(n = 15)
Fatal
(n = 16)
p-Value
1 (71%) NS 6/15 (40%) 15/16 (94%) 0.002
1 (71%) NS 10/15 (67%) 11/16 (69%) NS
1 (76%) 0.0214 9/15 (60%) 10/16 (63%) NS
1 (90%) NS 12/15 (80%) 14/16 (88%) NS
1 (71%) NS 10/15 (67%) 12/15 (80%) NS
 (73%) NS 10/15 (67%) 3/5 (60%) NS
1 (86%) NS 14/15 (93%) 11/16 (69%) NS
 (25%) NS 2/11 (18%) 4/15 (27%) NS
 (29%) NS 0/8 (0%) 6/14 (43%) 0.051
 (31%) NS 1/11 (9%) 8/15 (53%) 0.036
 (56%) NS 4/11 (36%) 8/15 (53%) NS
6 (69%) NS 6/11 (55%) 15/15 (100%) 0.007
2 (83%) NS 7/8 (88%) 13/14 (93%) NS
 (36%) NS 4/10 (40%) 3/11 (27%) NS
6 (63%) NS 4/11 (36%) 12/15 (80%) 0.043
1 (100%) NS 15/15 (100%) 16/16 (100%) NS
l 7/21
)
NS Sputum 1/15 (7%);
stool 5/15 (33%);
skin lesions 2/15
(13%)
Stool 2/16 (13%);
CSF 2/16 (13%);
peritoneal 2/16 (13%);
pleural 2/16 (13%);
skin lesions 1/16 (6%)
NS
1 (71%) NS 14/15 (93%) 6/16 (38%) 0.002
ransferase; CRP, C-reactive protein; CSF, cerebrospinal ﬂuid; Hb, hemoglobin; LDH,
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the children, respectively. Overall the P. aeruginosa bacteremia was
deemed to be secondary in 11 cases (seven gastroenteritis, two
pneumonia, one urinary tract infection, and one parapharyngeal
abscess). The fatality rate between primary and secondary bacter-
emia cases was not signiﬁcantly different (6/11 vs.10/20; p > 0.05).
Of note, ﬁve of the 21 children with underlying conditions had been
in an intensive care unit in the previous month.
Laboratory ﬁndings are summarized in Table 3, and are
compared between previously healthy children and those with
underlying conditions, and between fatal and non-fatal cases.
Overall, the incidence of leukopenia at the time of P. aeruginosa
bacteremia was signiﬁcantly higher in fatal than in non-fatal cases
(94% vs. 40%; p = 0.002), and fatal cases were also more likely to
have an elevated aspartate aminotransferase (53% vs. 9%; p < 0.05),
a low prealbumin A (100% vs. 55%; p < 0.05), and an elevated
lactate dehydrogenase concentration (80% vs. 36%; p < 0.05). Few
differences were noted when previously healthy children were
compared to those with underlying illnesses, with only the
incidence of admission thrombocytopenia reaching statistical
signiﬁcance (30% vs. 76%; p < 0.05).
Immunology studies were performed in 15 (48%) of the
children, including six who were previously healthy. Serum
immunoglobulin concentrations (IgA, IgG, IgE, and IgM) were
normal for age in 11 of the 15 cases. Four children, two previously
healthy, had abnormal results: two with low IgA and two others
with low IgG concentrations. One of these four children, an 8-
month-old child who died, had very low total serum globulin
concentrations and may have had hypogammaglobulinemia or
agammaglobulinemia. T cells, B cells, and T cell subsets, along with
the CD4:CD8 ratio, were normal in the eight children tested. All 31
children tested negative for HIV and all 20 of those investigated for
chronic granulomatous disease tested negative.
None of the 31 blood isolates of P. aeruginosa was multi-
resistant. All were susceptible to amikacin, gentamicin, imipenem,
meropenem, and levoﬂoxacin, all but one was susceptible to
piperacillin/tazobactam, all but two to cefepime, and all but three
to cefoperazone/sulbactam or ceftazidime. No major differences
were noted in antibiotic sensitivity between community-acquired
and nosocomial infections (p > 0.05).
Empiric antibiotics were administered to all 31 children, but the
initial antibiotic regimen selected in 11 of the 31 cases was
ceftriaxone or cefotaxime, neither of which is recommended for
the treatment of pseudomonal infections. This included six of the
21 children (29%) with an underlying predisposing condition
(three with a malignancy and three with other predisposing
factors) and ﬁve of the 10 (50%) who were previously healthy
(p > 0.05). Overall, signiﬁcantly more children with non-fatal P.
aeruginosa had an initial antibiotic regimen that covered P.
aeruginosa than those who died (14/15 vs. 6/16, p = 0.002). The
death rate was signiﬁcantly higher in patients with neutropenia
and inadequate P. aeruginosa initial coverage (7/8, 88%) than in
patients with neutropenia and adequate microbe coverage (4/13,
31%; p < 0.05).
4. Discussion
The results from this 5-year cohort study conﬁrm that P.
aeruginosa bacteremia is still an uncommon ﬁnding among
hospitalized children,1,5,6,8 representing only 2.6% of all positive
blood cultures over the 5-year period. Bacteremia occurred in both
children with and without underlying predisposing conditions,
with one third of the cases occurring in previously healthy
children, which is similar to previously reported rates.2,8 Unfortu-
nately, the case fatality rate was high (52%), much higher than the
14.5% in the recent 10-year study of children in Korea.13 A majordifference, however, was that children with underlying conditions
predominated in the Korean study (59 of 62 cases).13 In our study,
children both with and without underlying conditions who did not
receive initial antibiotic coverage for P. aeruginosa were particu-
larly at risk, with a fatality rate of 91% compared to 38% for those
who did. This drives home the critical importance of early
appropriate coverage for P. aeruginosa. Multi-resistant P. aerugi-
nosa was not a problem in this study in contrast to the Korean
cohort study, although a fairly similar percentage of patients had
been in the intensive care unit in the previous month (24% vs. 21%
in the Korean study), the risk factor for multi-resistant P.
aeruginosa noted in the Korean study.Mortality rates in this study
did not differ signiﬁcantly between previously healthy children
and patients with underlying conditions. It was whether or not
they received appropriate treatment that was crucial. Although the
literature on P. aeruginosa sepsis in previously healthy children is
sparse, published studies suggest that this microbe can cause
serious illness with a high mortality rate in children without any
underlying disease.6,8–11
While fever, poor feeding, decreased activity, and tachycardia
were very common presenting features, present in 90–100% of the
cases, these ﬁndings would not be helpful in distinguishing
children ill with P. aeruginosa bacteremia from those with many
other serious illnesses. Even the addition of diarrhea (58%) to the
symptom grouping would not be speciﬁc enough to make a
clinician suspicious of infection with P. aeruginosa.
In contrast, some presenting features were indicative of a poor
prognosis. The presence of abdominal distension, GI hemorrhage, and/
or shock was especially foreboding, as variations on this combination
occurred in 13 of the 16 fatal cases. A necrotizing bowel has previously
been described in children with community-acquired P. aeruginosa
bacteremia.5,14 The microbe has been reported to colonize the stool of
2–24% of healthy adults.15 While carriage rates in infancy and
childhood are less well deﬁned, one study reported P. aeruginosa-
positive stools in up to 50% of newborn infants,16with carriage rates of
infant P. aeruginosa likely reﬂective of perinatal/nosocomial acquisi-
tion or environmental contamination of food sources.
Neutropenia, a well reported ﬁnding in cases of P. aeruginosa
bacteremia, occurred in 21/31 (68%) patients in this cohort, but did
not distinguish fatal from non-fatal cases. However, the presence
of leukopenia (total white cell count <2  109/l) was more
discriminatory, with 94% of fatal cases being leukopenic compared
to 40% of non-fatal cases. Signiﬁcantly, patients with neutropenia
and inadequate P. aeruginosa initial antibiotic coverage were more
likely to die than patients with neutropenia and adequate microbe
coverage, reinforcing the importance of considering broad-
spectrum antibiotics in any septic-appearing child with neutrope-
nia, especially if overall leukopenia is also present.
Not surprisingly, in addition to neutropenia and leukopenia,
thrombocytopenia (19/31; 61%) and anemia (26/31; 84%) were
common in this study. P. aeruginosa is a known producer of
endotoxin. While not as potent as the toxins made by some other
Gram-negative bacteria, P. aeruginosa endotoxin is still capable of
triggering cytokine pathways with resultant sepsis syndrome and
shock. P. aeruginosa endotoxin can also cause bone marrow
suppression, helping to explain the high frequency of hematologi-
cal abnormalities found in these patients.12,17,18
Ecthyma gangrenosum has been reported to occur in 1.3% to
2.8% of patients with P. aeruginosa bacteremia and less frequently
in patients without bacteremia.18 The reported rate of 13% in this
cohort is higher, and this condition was only seen in previously
healthy children – an ominous ﬁnding, as all four died. Others have
also noted higher rates of ecthyma gangrenosum in previously
healthy persons with P. aeruginosa infection than in patients with
underlying medical conditions.4,5 It is hypothesized that a certain
degree of immunocompetence may be required to mount the
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tic of this skin lesion.5
P. aeruginosa overgrowth in the GI tract may also predispose
colonized patients to extraintestinal manifestations due to the
same organism, including pneumonia.19 In our cohort, seven (23%)
had pure growth of P. aeruginosa in their stools. Of note, 42% had
non-blood sites of P. aeruginosa infection as well as bacteremia,
underlining the critical importance of a full clinical assessment in
these children. The ﬁnding of P. aeruginosa infection beyond
bacteremia may necessitate modiﬁcations to patient management
and may have a role to play in prognostication.
Previously healthy children in this study suffered from more
seizures, diarrhea, abdominal distension, and GI hemorrhage than
those with underlying conditions. Combined with the high mortality
associated with abdominal distension and GI hemorrhage, it would
seem imperative to consider P. aeruginosa when evaluating
previously healthy young children with presumed infectious
diarrhea, especially when they present with severe disease,
associated hematological abnormalities such as neutropenia and
leukopenia, and ecthyma gangrenosum. Additional laboratory
ﬁndings such as hyponatremia, a low prealbumin A, and hypoalbu-
minemia might further prompt a clinician to consider adding
empiric anti-pseudomonal coverage until the blood culture ﬁndings
are known, although these serum markers remain nonspeciﬁc. The
importance of a low prealbumin is unknown as this has not
previously been systematically assessed in such patients.
In summary, P. aeruginosa remains a serious but uncommon
cause of bacteremia in children. While readily suspected in
children with well known predisposing conditions such as
malignancy, especially if neutropenia is present, it may be
overlooked if neutropenia is not present and is rarely considered
if a child is previously healthy. This study conﬁrms how critical
initial coverage for P. aeruginosa is for survival. If suspicions are
raised due to clinical presentation and laboratory ﬁndings,
coverage must not be delayed.
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